| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.548 | 18.943 | 46.518 | 31.431 | 24.096 | 11.456 | 10.926 | 11.075 | 19.420 | 10.859 |
| Total Income - EUR | 6.550 | 18.943 | 46.518 | 31.431 | 24.096 | 11.456 | 11.937 | 11.075 | 21.424 | 10.859 |
| Total Expenses - EUR | 6.279 | 16.792 | 21.879 | 24.888 | 23.246 | 19.064 | 11.950 | 11.648 | 18.855 | 18.766 |
| Gross Profit/Loss - EUR | 271 | 2.151 | 24.639 | 6.543 | 851 | -7.608 | -13 | -573 | 2.569 | -7.907 |
| Net Profit/Loss - EUR | 75 | 1.773 | 22.784 | 6.229 | 610 | -7.771 | -371 | -906 | 2.355 | -8.233 |
| Employees | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Iunonamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.803 | 48.569 | 41.882 | 35.357 | 29.027 | 22.939 | 17.014 | 11.691 | 5.321 | 0 |
| Current Assets | 7.693 | 7.658 | 17.612 | 17.356 | 11.862 | 11.451 | 12.878 | 6.894 | 5.533 | 3.378 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 916 | 0 | 0 | 0 | 0 |
| Cash | 7.693 | 7.658 | 17.612 | 17.356 | 11.862 | 10.535 | 12.878 | 6.894 | 5.533 | 3.378 |
| Shareholders Funds | 9.147 | 10.826 | 33.427 | 39.042 | 38.896 | 30.387 | 29.342 | 17.983 | 9.569 | 1.283 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 349 | 45.401 | 26.068 | 13.671 | 1.993 | 4.003 | 550 | 602 | 1.285 | 2.095 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Iunonamed S.r.l.